In 2023, the FDA received over 1.4 million reports of adverse drug reactions, many of which involved violence, suicidal thoughts, or actual harm to self and others. This data highlights the critical need for greater transparency, accountability, and vigilance in prescribing and monitoring medications.

MISSD emphasizes the urgency of educating patients and healthcare providers about these risks, ensuring that side effects — particularly those that can lead to harm or violence — are taken seriously, tracked, and prevented whenever possible. Read the full article at: https://www.aol.com/news/fda-adverse-event-data-reveals-194654547.html.